We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
CityMunch allows restaurants to catch potential customers through real time offer platforms. Allowing restaurants to attract customers specifically in the least busiest times of the day. CityMunch will use the funding to expand throughout the city.
days to go: Expired investment: £174,582
M Restaurants are based around 5 individual elements; Raw, Grill, Bar, Wine and Den. M Restaurants offer 400 wines ranging from £10 a bottle to £4,000 a bottle. M have cuts of beef from all over the world including Argentina and France.
days to go: Expired investment: £1,585,600
A crisps company with the mission of making tasty and healthy snacks. Emily Crisps are vegan, gluten-free, halal and kosher certified, as well as being 1 of a 5 per day. Their products are sold in major grocery stores such as Sainsbury's and Tesco, which are responsible for 50% of the company's revenue. Emily Crisps are well-established in the UK and are now seeking funds to expand to the US, with a dedicated marketing campaign and sales team.
days to go: Expired investment: £1,048,030
Improving urban mobility by offering a bike sharing service to reduce congestion and pollution whilst increasing physical activity. cycle.land has recently entered a partnership with Youon, the largest bike share company in China, to deliver their services all over Europe. The fleet will consist of regular bicycles, in addition to e-bikes, e-scooters and e-cars. cycle.land has also worked in conjunction with local councils, Transport for London and local boroughs to introduce dock less mobility companies in the UK.
days to go: Expired investment: £331,963
EeBriaTrade is a craft beer, cider and other drinks distributor, representing over 500 top breweries from across the UK and abroad. EeBria adopts a unique B2B marketplace model where, unlike other conventional distributors, the operation is entirely online. Since its launch in 2015, EeBria has witnessed strong growth in the UK with over 100% YoY growth in 2018, c.200% in 2017 and c.600% in 2016, and total sales of over £6.2m. It is raising funds to make its business global and planning to launch in at least eight new countries in 2019. EeBriaTrade is expected to see even faster growth in 2019 due to progress with Pub Chains, and because of new deals signed at the end of 2018 with Costcutter (1,700 stores) and NISA (2,000 stores).
days to go: Expired investment: £235,780
Fix Radio is the UK's first commercial radio station targeted at tradespeople. They will be initially highly targeted towards the London market of 650,000 tradespeople before expanding nationwide. Currently there is £30 million spent annually on radio advertising targeted at this market.
days to go: Expired investment: £269,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph